Skip to main content
Delfa

← All trials/NCT06843512

Recruiting

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet

Asset

GLP-1 / incretin class catch-all

Listed sites

1

Recruiting sites

1

Estimated enrollment

25

Study population

Obesity / overweight

Eligibility highlights

•BMI ≥25

Primary endpoints

•Total Weight of Food Selected in the VR Buffet•Total Calories of Food Selected in the VR Buffet•Energy Density of Food Selected in the VR Buffet

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06843512
Org study IDSTUDY00026642

Timeline

Milestones

Study first posted2025-02-25actual
Study start2025-07-15actual
Last update posted2025-09-10actual
Primary completion2026-12estimated (month precision)
Study completion2026-12estimated (month precision)

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age18 Years
SexAll
Healthy volunteersNot accepted
Sampling methodNon probability sample

Study population text

Participants will be identified from a list of medical patients prescribed GLP-1 medication by their physicians (located in offices near State College or Hershey, PA) and who volunteered to be contacted regarding studies they are eligible for.

Inclusion criteria

•Adults (18+) with overweight or obesity (BMI >25 kg/m2)
•Not currently taking an incretin-based medication at baseline
•Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
•Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
•Fluent in English

Exclusion criteria

•Adults (18+) without overweight or obesity
•<18 years of age at time of testing
•Adults not taking a GLP-1 Medication
•Adults taking a compound GLP-1
•Adults on GLP-1 medication for longer than 2 weeks at baseline
•Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
•Not fluent in English

Endpoints (11)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)
6
Weight & body composition
3
Patient-reported / QoL
2

Weight & body composition

3 endpoints
Primary/protocol endpoint

Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Secondary/protocol endpoint

Change in Baseline Weight Watchers Food Noise Score at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Other/protocol endpoint

Change in Baseline BMI at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Patient-reported / QoL

2 endpoints
Secondary/protocol endpoint

Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Secondary/protocol endpoint

Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Other (unclassified)

6 endpoints
Primary/protocol endpoint/low confidence

Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Primary/protocol endpoint/low confidence

Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Primary/protocol endpoint/low confidence

Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Secondary/protocol endpoint/low confidence

Change in Baseline Adult Eating Behavior Score at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Secondary/protocol endpoint/low confidence

Change in Baseline General Food Craving-Trait Scale Score at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Secondary/protocol endpoint/low confidence

Change in Baseline Buffet Food Liking Scores at 3 Months

Time frame:Baseline and 3 months

change from baseline, improvement

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 6, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.